Endogenous retroviruses

With us and against us

Thomas J. Meyer, Jimi L. Rosenkrantz, Lucia Carbone, Shawn Chavez

Research output: Contribution to journalShort survey

15 Citations (Scopus)

Abstract

Mammalian genomes are scattered with thousands of copies of endogenous retroviruses (ERVs), mobile genetic elements that are relics of ancient retroviral infections. After inserting copies into the germ line of a host, most ERVs accumulate mutations that prevent the normal assembly of infectious viral particles, becoming trapped in host genomes and unable to leave to infect other cells. While most copies of ERVs are inactive, some are transcribed and encode the proteins needed to generate new insertions at novel loci. In some cases, old copies are removed via recombination and other mechanisms. This creates a shifting landscape of ERV copies within host genomes. New insertions can disrupt normal expression of nearby genes via directly inserting into key regulatory elements or by containing regulatory motifs within their sequences. Further, the transcriptional silencing of ERVs via epigenetic modification may result in changes to the epigenetic regulation of adjacent genes. In these ways, ERVs can be potent sources of regulatory disruption as well as genetic innovation. Here, we provide a brief review of the association between ERVs and gene expression, especially as observed in pre-implantation development and placentation. Moreover, we will describe how disruption of the regulated mechanisms of ERVs may impact somatic tissues, mostly in the context of human disease, including cancer, neurodegenerative disorders, and schizophrenia. Lastly, we discuss the recent discovery that some ERVs may have been pressed into the service of their host genomes to aid in the innate immune response to exogenous viral infections.

Original languageEnglish (US)
Article number23
JournalFrontiers in Chemistry
Volume5
Issue numberAPR
DOIs
StatePublished - 2017

Fingerprint

Genes
Interspersed Repetitive Sequences
Gene expression
Innovation
Tissue
Proteins

Keywords

  • Endogenous retrovirus
  • Genome
  • Human disease
  • Innate immunity
  • Placenta
  • Pre-implantation embryo
  • Stem cells

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Endogenous retroviruses : With us and against us. / Meyer, Thomas J.; Rosenkrantz, Jimi L.; Carbone, Lucia; Chavez, Shawn.

In: Frontiers in Chemistry, Vol. 5, No. APR, 23, 2017.

Research output: Contribution to journalShort survey

Meyer, Thomas J. ; Rosenkrantz, Jimi L. ; Carbone, Lucia ; Chavez, Shawn. / Endogenous retroviruses : With us and against us. In: Frontiers in Chemistry. 2017 ; Vol. 5, No. APR.
@article{9b921938d15b4bcb8edbe4020bc595bb,
title = "Endogenous retroviruses: With us and against us",
abstract = "Mammalian genomes are scattered with thousands of copies of endogenous retroviruses (ERVs), mobile genetic elements that are relics of ancient retroviral infections. After inserting copies into the germ line of a host, most ERVs accumulate mutations that prevent the normal assembly of infectious viral particles, becoming trapped in host genomes and unable to leave to infect other cells. While most copies of ERVs are inactive, some are transcribed and encode the proteins needed to generate new insertions at novel loci. In some cases, old copies are removed via recombination and other mechanisms. This creates a shifting landscape of ERV copies within host genomes. New insertions can disrupt normal expression of nearby genes via directly inserting into key regulatory elements or by containing regulatory motifs within their sequences. Further, the transcriptional silencing of ERVs via epigenetic modification may result in changes to the epigenetic regulation of adjacent genes. In these ways, ERVs can be potent sources of regulatory disruption as well as genetic innovation. Here, we provide a brief review of the association between ERVs and gene expression, especially as observed in pre-implantation development and placentation. Moreover, we will describe how disruption of the regulated mechanisms of ERVs may impact somatic tissues, mostly in the context of human disease, including cancer, neurodegenerative disorders, and schizophrenia. Lastly, we discuss the recent discovery that some ERVs may have been pressed into the service of their host genomes to aid in the innate immune response to exogenous viral infections.",
keywords = "Endogenous retrovirus, Genome, Human disease, Innate immunity, Placenta, Pre-implantation embryo, Stem cells",
author = "Meyer, {Thomas J.} and Rosenkrantz, {Jimi L.} and Lucia Carbone and Shawn Chavez",
year = "2017",
doi = "10.3389/fchem.2017.00023",
language = "English (US)",
volume = "5",
journal = "Frontiers in Chemistry",
issn = "2296-2646",
publisher = "Frontiers Media S. A.",
number = "APR",

}

TY - JOUR

T1 - Endogenous retroviruses

T2 - With us and against us

AU - Meyer, Thomas J.

AU - Rosenkrantz, Jimi L.

AU - Carbone, Lucia

AU - Chavez, Shawn

PY - 2017

Y1 - 2017

N2 - Mammalian genomes are scattered with thousands of copies of endogenous retroviruses (ERVs), mobile genetic elements that are relics of ancient retroviral infections. After inserting copies into the germ line of a host, most ERVs accumulate mutations that prevent the normal assembly of infectious viral particles, becoming trapped in host genomes and unable to leave to infect other cells. While most copies of ERVs are inactive, some are transcribed and encode the proteins needed to generate new insertions at novel loci. In some cases, old copies are removed via recombination and other mechanisms. This creates a shifting landscape of ERV copies within host genomes. New insertions can disrupt normal expression of nearby genes via directly inserting into key regulatory elements or by containing regulatory motifs within their sequences. Further, the transcriptional silencing of ERVs via epigenetic modification may result in changes to the epigenetic regulation of adjacent genes. In these ways, ERVs can be potent sources of regulatory disruption as well as genetic innovation. Here, we provide a brief review of the association between ERVs and gene expression, especially as observed in pre-implantation development and placentation. Moreover, we will describe how disruption of the regulated mechanisms of ERVs may impact somatic tissues, mostly in the context of human disease, including cancer, neurodegenerative disorders, and schizophrenia. Lastly, we discuss the recent discovery that some ERVs may have been pressed into the service of their host genomes to aid in the innate immune response to exogenous viral infections.

AB - Mammalian genomes are scattered with thousands of copies of endogenous retroviruses (ERVs), mobile genetic elements that are relics of ancient retroviral infections. After inserting copies into the germ line of a host, most ERVs accumulate mutations that prevent the normal assembly of infectious viral particles, becoming trapped in host genomes and unable to leave to infect other cells. While most copies of ERVs are inactive, some are transcribed and encode the proteins needed to generate new insertions at novel loci. In some cases, old copies are removed via recombination and other mechanisms. This creates a shifting landscape of ERV copies within host genomes. New insertions can disrupt normal expression of nearby genes via directly inserting into key regulatory elements or by containing regulatory motifs within their sequences. Further, the transcriptional silencing of ERVs via epigenetic modification may result in changes to the epigenetic regulation of adjacent genes. In these ways, ERVs can be potent sources of regulatory disruption as well as genetic innovation. Here, we provide a brief review of the association between ERVs and gene expression, especially as observed in pre-implantation development and placentation. Moreover, we will describe how disruption of the regulated mechanisms of ERVs may impact somatic tissues, mostly in the context of human disease, including cancer, neurodegenerative disorders, and schizophrenia. Lastly, we discuss the recent discovery that some ERVs may have been pressed into the service of their host genomes to aid in the innate immune response to exogenous viral infections.

KW - Endogenous retrovirus

KW - Genome

KW - Human disease

KW - Innate immunity

KW - Placenta

KW - Pre-implantation embryo

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85019646604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019646604&partnerID=8YFLogxK

U2 - 10.3389/fchem.2017.00023

DO - 10.3389/fchem.2017.00023

M3 - Short survey

VL - 5

JO - Frontiers in Chemistry

JF - Frontiers in Chemistry

SN - 2296-2646

IS - APR

M1 - 23

ER -